STAT5 does not drive steroid resistance in T-cell acute lymphoblastic leukemia despite the activation of BCL2 and BCLXL following glucocorticoid treatment by Van der Zwet, Jordy C G, Cordo', Valentina, Buijs-Gladdines, Jessica G C A M, Hagelaar, Rico, Smits, Willem K, Vroegindeweij, Eric, Graus, Laura T M, Poort, Vera, Nulle, Marloes, Pieters, Rob, Meijerink, Jules P P

Get full text

The role of the mineralocorticoid receptor in steroidinduced cytotoxicity in pediatric acute lymphoblastic leukemia by Van Hulst, Annelienke M, Van der Zwet, Jordy C G, Buijs-Gladdines, Jessica G C A M, Smits, Willem K, Fiocco, Marta, Pieters, Rob, Van Leeuwen, Frank N, Van den Heuvel-Eibrink, Marry M, Van den Akker, Erica L T, Meijerink, Jules P P

Get full text

Reversal of IKZF1-induced glucocorticoid resistance by dual targeting of AKT and ERK signaling pathways by Butler, Miriam, Vervoort, Britt M.T., van Ingen Schenau, Dorette S., Jongeneel, Lieneke, van der Zwet, Jordy C.G., Marke, René, Meijerink, Jules P.P., Scheijen, Blanca, van der Meer, Laurens T., van Leeuwen, Frank N.

Get full text

MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance by van der Zwet, Jordy C. G., Buijs-Gladdines, Jessica G. C. A. M., Cordo’, Valentina, Debets, Donna O., Smits, Willem K., Chen, Zhongli, Dylus, Jelle, Zaman, Guido J. R., Altelaar, Maarten, Oshima, Koichi, Bornhauser, Beat, Bourquin, Jean-Pierre, Cools, Jan, Ferrando, Adolfo A., Vormoor, Josef, Pieters, Rob, Vormoor, Britta, Meijerink, Jules P. P.

Get full text

T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies by Cordo', Valentina, van der Zwet, Jordy C G, Canté-Barrett, Kirsten, Pieters, Rob, Meijerink, Jules P P

Get full text

The role of the mineralocorticoid receptor in steroid-induced cytotoxicity in pediatric acute lymphoblastic leukemia by Van Hulst, Annelienke M., Van der Zwet, Jordy C.G., Buijs-Gladdines, Jessica G.C.A.M., Smits, Willem K., Fiocco, Marta, Pieters, Rob, Van Leeuwen, Frank N., Van den Heuvel-Eibrink, Marry M., Van den Akker, Erica L.T., Meijerink, Jules P.P.

Get full text

MAPK-ERK Pathway Activation: The Achilles' Heel of IL-7R‒Induced Steroid Resistance by Van Der Zwet, Jordy C.G., Buijs-Gladdines, Jessica G.C.A.M., Smits, Willem K., Chen, Zhongli, Meijerink, Jules P.P.

Get full text

STAT5 does not drive steroid resistance in T-cell acute lymphoblastic leukemia despite the activation of BCL and BCLXL following glucocorticoid treatment by van der Zwet, Jordy C.G., Cordo’, Valentina, Buijs-Gladdines, Jessica G.C.A.M., Hagelaar, Rico, Smits, Willem K., Vroegindeweij, Eric, Graus, Laura T.M., Poort, Vera M., Nulle, Marloes, Pieters, Rob, Meijerink, Jules P.P.

Get full text

The Clinical and Functional Relevance of the Transforming AKT E17K Mutation in T-ALL by Van Der Zwet, Jordy C.G., Buijs-Gladdines, Jessica G.C.A.M., Mollova, Izabela, Graus, Laura, Bos, Frank L., Rios, Anne C., Meijerink, Jules P.P.

Get full text

Multi-omic approaches to improve outcome for T-cell acute lymphoblastic leukemia patients by van der Zwet, Jordy C.G., Cordo', Valentina, Canté-Barrett, Kirsten, Meijerink, Jules P.P.

Get full text

Recurrent NR3C1 Aberrations at First Diagnosis Relate to Steroid Resistance in Pediatric T‐Cell Acute Lymphoblastic Leukemia Patients by Zwet, Jordy C. G., Smits, Willem, Buijs‐Gladdines, Jessica G. C. A. M., Pieters, Rob, Meijerink, Jules P. P.

Get full text

The Central Role of MAPK-ERK Signaling in IL7-Dependent and IL7-Independent Steroid Resistance Reveals a Broad Application of MEK-Inhibitors Compared to JAK1/2-Inhibition in T-ALL by Van Der Zwet, Jordy C.G., Buijs-Gladdines, Jessica G.C.A.M., Cordo', Valentina, Debets, Donna, Smits, Willem K., Chen, Zhongli, Dylus, Jelle, Zaman, Guido, Altelaar, Maarten, Oshima, Koichi, Bornhauser, Beat, Bourquin, Jean-Pierre, Cools, Jan, Ferrando, Adolfo A., Vormoor, Josef, Pieters, Rob, Vormoor, Britta Julia, Meijerink, Jules P.P.

Get full text